2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Validity and reliability of the test d evaluation des membres superieurs de personnes agees (TEMPA) to assess upper limb in Parkinson’s disease

C.L. Correa, P.R. de-Freitas, A.E. Lemos, S.M. Michaelsen, A. Swarowsky (Rio de Janeiro, Brazil)
Validity and reliability of the Turkish version of the scales for outcomes in Parkinson’s disease-autonomic questionnaire (SCOPA-AUT)

H. Yasar, M.G. Senol, S. Tasdemir, U.H. Ulas, S. Alay (Ankara, Turkey)
Valproate-associated parkinsonism – A critical review of the literature

F. Brugger, K.P. Bhatia, F.M.C. Besag (St. Gallen, Switzerland)
Valproate-induced reversible parkinsonism – A case series

R.M. Simões, N. Inácio, V.B. Silva, A. Arraiolos, P. Alegria, N. Canas, J. Vale (Loures, Portugal)
VANTAGE trial: Three year outcomes of a prospective, multi-center trial evaluating deep brain stimulation with a new multiple-source, constant-current rechargeable system in Parkinson’s disease

L. Timmerman, R. Jain, L. Chen, T. Brucke, F. Seijo, E. Suarez San Martin, C. Haegelen, M. Verin, V. Visser-Vandewalle, M.T. Barbe, S. Gill, A. Whone, M. Porta, D. Servello, F. Alesch (Cologne, Germany)
Variability in the ideal target of GPi DBS for Parkinson’s disease requires advanced direct targeting for optimal results

J.D. Hilliard, T. Morishita, M.S. Okun, K.D. Foote (Gainesville, FL, USA)
Vascular degeneration in Parkinson’s disease

J. Guan, P. Yang, R.L.M. Faill, M. Dragunow, H.J. Waldvogel (Auckland, New Zealand)
Verb naming in hypokinetic and hyperkinetic movement disorders: Preliminary results

E. Bayram, M.C. Akbostanci (Ankara, Turkey)
Verbal fluency deficits in essential tremor patients: Underlying structural changes

E.A. Pelzer, C. Nelles, D.J. Pedrosa, L. Burghaus, C. Eggers, C. Melzer, M. Tittgemeyer, L. Timmermann (Cologne, Germany)
Verbatim patient-reported outcomes and trails making test B (TMT-B) performance in the REACH2HD trial

J.L. Purks, A. Zeymo, N.M. Shara, K.E. Anderson, I. Shoulson (Washington, DC, USA)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z